“I am on a volunteer fire department. I am used to going, and saving, and defending people’s property with a fire hose. And now I am on this end. It’s overwhelming.” Watch now to hear the emotional story of Randy Rohn, a volunteer firefighter who got a second shot at life thanks to a life-saving shock from his ASSURE System.
Kestra Medical Technologies, Inc.
医疗设备制造业
Kirkland，WA 25,438 位关注者
Kestra's mission is to provide innovative, intuitive medical technologies to protect and support at-risk patients.
关于我们
At Kestra, we stand for patients at-risk and the people who care for them. Together we work to protect, support, and empower them with wearable technologies, tools, and better answers as they navigate life’s most challenging medical events. Cardiovascular disease is the number one cause of death globally. We’re taking a fresh approach to cardiac monitoring and delivery of definitive therapy with wearable products and applications. We aim to make the entire recovery process easier for patients by bringing comfort and assurance to them—along with advanced clinical insights and tools to their medical care teams. Kestra is a privately held, Bain Capital portfolio company, headquartered in Kirkland, Washington USA. Visit us at www.kestramedical.com
- 网站
-
http://www.kestramedical.com
Kestra Medical Technologies, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 51-200 人
- 总部
- Kirkland，WA
- 类型
- 私人持股
- 创立
- 2014
地点
-
主要
获取路线
3933 Lake Washington Blvd NE
Suite 200
US，WA，Kirkland，98033
Kestra Medical Technologies, Inc.员工
-
Joe Kelty
Experienced medical device sales leader and top performer. Multiple presidents club winner.
-
Leo Gilbert
-
Jonathan Niegowski
Principal Technical Product Manager at Kestra Medical Technologies, Inc.
-
Jeff Laub
Global Leader; General Management | Commercial Operations | Supply Chain | Quality | Customer Service | Medical Device
动态
-
New Clinical Evidence from Kestra Our latest research, presented at ACC 2025 and now published in JACC, highlights critical insights from over 4,700 patients with newly diagnosed dilated cardiomyopathy (DCM) using the ASSURE wearable cardioverter defibrillator (WCD). Presented by Dr. Kelley Branch from UW Medicine, the data revealed a 2.1% incidence of life-threatening arrhythmias within a median of just 38 days but with a 100% successful WCD conversion rate. This challenges outdated assumptions and underscores the need for early protection. Read the full abstract: https://lnkd.in/gsCKcQeZ
-
-
Diversity is in our DNA. During Women’s History Month, we’re proud to recognize the women who are shaping Kestra’s future. Last week, they led the way as we took the company public on Nasdaq In fact, our lead SEC counsel, lead Intellectual Property counsel, and principal investigators of our clinical studies are women—standing as proof of our commitment to building and growing an inclusive company that mirrors the patients and providers we serve. #KestraIPO #WomensHistoryMonth
-
-
Reliving the Moment! Kestra team members from across the country joined in to celebrate our Nasdaq bell ringing—an achievement we’re all proud to share. #KestraIPO #Nasdaq
-
Kestra Medical Technologies, Inc.转发了
⚡ Combining tech with empathy-driven innovation: Kestra Medical Technologies, Inc. is empowering cardiac patients and providers with diagnostic and therapeutic technologies. 🎉 We’re so excited $KMTS is now #NasdaqListed! Catch the recap of their big day. ⬇️
-
One Celebration, Many Places From Times Square to screens across the country, the Kestra team is celebrating this achievement and everything it represents—together! #KestraIPO #Nasdaq
-
-
Kestra Medical Technologies, Inc.转发了
🫀 285m+ covered lives. 2 styles. 23+ hours median wear time per day. >95% first shock efficacy. 💪 Kestra Medical Technologies, Inc.: revolutionizing cardiac protection. 🎊 Now trading on Nasdaq under $KMTS.